Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy.
about
Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM studyInfluence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virusMenopause-associated metabolic manifestations and symptomatology in HIV infection: a brief review with research implicationsAssociation of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysisHIV infection and the risk of acute myocardial infarction.Achieving American Diabetes Association goals in HIV-seropositive patients with diabetes mellitusIncidence and predictors of hypertension in adults with HIV-initiating antiretroviral therapy in south-western Uganda.Getting to 90-90-90 in paediatric HIV: What is needed?Effects of aging and smoking on carotid intima-media thickness in HIV-infection.Pharmacokinetic and metabolic effects of American ginseng (Panax quinquefolius) in healthy volunteers receiving the HIV protease inhibitor indinavir.Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study).Adherence to Mediterranean diet is favorably associated with metabolic parameters in HIV-positive patients with the highly active antiretroviral therapy-induced metabolic syndrome and lipodystrophy.The association between alcohol consumption and prevalent cardiovascular diseases among HIV-infected and HIV-uninfected men.Antiretroviral therapy exposure and insulin resistance in the Women's Interagency HIV study.Polypharmacy in the HIV-infected older adult population.Anthropometric and Nutritional Profile of People Living with HIV and AIDS in India: an AssessmentLIPODYSTROPHY SYNDROME IN HIV-INFECTED CHILDREN ON HAART.Biomarkers of vascular dysfunction in children infected with human immunodeficiency virus-1.Relationship of body composition, metabolic status, antiretroviral use, and HIV disease factors to endothelial dysfunction in HIV-infected subjects.Lipodystrophy defined by Fat Mass Ratio in HIV-infected patients is associated with a high prevalence of glucose disturbances and insulin resistance.HIV protease inhibitors acutely impair glucose-stimulated insulin release.HIV-associated lipodystrophy.Clinical evaluation and management of metabolic and morphologic abnormalities associated with human immunodeficiency virus.Quality of life in individuals living with HIV/AIDS attending a public sector antiretroviral service in Cape Town, South Africa.Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin.Relationship of ethnicity and CD4 Count with glucose metabolism among HIV patients on Highly-Active Antiretroviral Therapy (HAART)Combined use of waist and hip circumference to identify abdominally obese HIV-infected patients at increased health risk.GS-8374, a novel HIV protease inhibitor, does not alter glucose homeostasis in cultured adipocytes or in a healthy-rodent model system.Evaluation and management of dyslipidemia in patients with HIV infection.HIV and HAART-Associated DyslipidemiaIntermuscular and subcutaneous adipose tissue distributions differ in HIV+ versus HIV-men and womenAging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions.High rate of coronary artery abnormalities in adolescents and young adults infected with human immunodeficiency virus early in life.Dyslipidemia and lipid management in HIV-infected patientsIncreased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men.The associations of regional adipose tissue with lipid and lipoprotein levels in HIV-infected men.Hypertriglyceridemia, Metabolic Syndrome, and Cardiovascular Disease in HIV-Infected Patients: Effects of Antiretroviral Therapy and Adipose Tissue Distribution.Insulin resistance predicts endothelial dysfunction and cardiovascular risk in HIV-infected persons on long-term highly active antiretroviral therapyMetabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population.Early factors in successful anti-HIV treatment.
P2860
Q24635177-6B0B883E-9199-4BEB-A664-48A36E49292CQ26851535-8A87B824-E04C-47EC-BA5D-5759D85EE6D7Q26865187-113EF362-2FEB-46A1-B6F8-09FCF2471069Q27000959-37375266-2A64-48F7-BAAB-ADEBBDEA800CQ27347231-93941184-F2A0-4CD8-AA2B-35ABA4A020EEQ28222271-D9971F83-D052-495C-A9AF-61EAC0C48441Q30278586-9D188F2D-ED19-412D-BF0D-F1D82F4B66C8Q30385352-DABFCBB7-3F98-4BDA-8FDD-EC86362B01B5Q30540864-34324572-3003-4250-AB4A-19B120061822Q33361454-8E3B98B8-E992-435C-81B7-A9CE716A415FQ33404972-6EBB1676-3A75-44F6-B5E6-851704441C7CQ33690814-9C4A846F-B55D-4336-ABF5-A83C2F235744Q33807791-D799AEDA-25A3-480C-8C38-B1909F7C689BQ33927532-67652C23-644F-455E-BBCE-F783BC04DFA9Q34037407-F3E97237-764F-4162-B65F-827D68A3019AQ34052126-E1B483D4-E56D-4B5E-9D97-A13CC3666783Q34058478-BFE4C3F2-9975-4C8E-987C-A61CBDBAE4CEQ34147987-B925DA9B-446E-4640-BB17-C405F69CC05BQ34213862-9E63A476-1A1F-4FF1-A79F-00950B1ECF30Q34367498-342F116D-34F3-4D50-AD74-846CF3E2A8CDQ34455624-A510B2F5-F8BA-49ED-90E1-FEA7B44F0293Q34459421-A474FFC9-AD3C-4FDB-B610-609576710AFCQ34461377-DDA8993A-EDCB-476D-AC01-B0BED415BF8FQ34486279-977387E8-4783-41FA-BCFA-1BB9AD0A4D92Q34637395-BE4F9558-D02A-4EAF-837A-C2602B43A1AFQ34680474-E48CD511-896C-4280-8DD8-04555FAD9699Q34734960-D05441BD-B8EC-489D-AD38-8D03ECA697CEQ34737804-2C16E8E7-FBBA-41BB-B040-8EC99CB29023Q34743413-CB326637-F400-4EE8-9A86-4C091E516241Q35020217-F6842ED0-4C6B-4D14-9A58-29ED7BB8B4BFQ35021199-E1CFB316-8FCA-4250-B377-48BCFCAD0073Q35088160-1430ABB3-28F4-4870-B9DB-EFF5A0369644Q35103300-C5A9E7A5-3C99-4779-BEDB-65211A9B09C8Q35160574-60F98338-CE13-463E-ABFB-51192EACB2AFQ35160580-DFA533E1-BF3C-4AA9-990C-E47EDE192429Q35166131-DB648B17-FE2F-4F57-8EF8-FD59C182D6A0Q35176441-2B804B82-2416-4FB0-A3D0-A63819B4750BQ35194049-91020E87-741D-4A2A-BB61-1446AD8A63A9Q35206670-6B32A454-672E-43A0-B796-BAA8765E5E23Q35207282-FB6EB420-A84F-43BC-A43B-80D42DC494D3
P2860
Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Metabolic abnormalities and ca ...... s infection and lipodystrophy.
@en
Metabolic abnormalities and ca ...... s infection and lipodystrophy.
@nl
type
label
Metabolic abnormalities and ca ...... s infection and lipodystrophy.
@en
Metabolic abnormalities and ca ...... s infection and lipodystrophy.
@nl
prefLabel
Metabolic abnormalities and ca ...... s infection and lipodystrophy.
@en
Metabolic abnormalities and ca ...... s infection and lipodystrophy.
@nl
P2093
P356
P1476
Metabolic abnormalities and ca ...... s infection and lipodystrophy.
@en
P2093
Corcoran C
D'Agostino RB
Grinspoon S
Rietschel P
P304
P356
10.1086/317541
P407
P577
2000-12-15T00:00:00Z